PFXF’s 6.7% Yield: Safe—Unless the Signal Flips Soon
The VanEck PFXF ETF focuses on non-financial preferred securities, offering a ~6.7% yield. But investors must watch c...
Warning signs of ineffective budgeting show up as overlooked leaks or mismatched priorities. Learn to spot them quickly and tighten your plan.
8,896 articlesThe VanEck PFXF ETF focuses on non-financial preferred securities, offering a ~6.7% yield. But investors must watch c...
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Citi boosts its Broadcom price target to $500 on expectations of solid AI-driven revenue in the upcoming April quarte...
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
Ford shares jumped roughly 7% as Q1 momentum and Ford Pro strength lifted the full-year EBIT outlook, putting Ford ah...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
Teva has climbed more than 100% in the last year, and analysts remain cautiously optimistic. Here’s why wall street t...
Tesla sits around $445 as Q1 margin gains meet AI roadmap momentum, prompting fresh Buy, Sell or Hold questions for i...
Powell's departure marks more than a leadership change. A divided FOMC and a market still riding AI-driven highs crea...
Barclays boosts its view on Charles Schwab after the firm guides for higher 2026 revenue and reports stronger Q1 resu...
P3 Health is shaping the future of value-based care with its platform. This guide breaks down what to expect from hea...
Cerebras exploded higher on its debut, but what comes next for investors? This guide breaks down the hype, the fundam...